107 related articles for article (PubMed ID: 26975214)
41. Virtual screening of potentially endocrine-disrupting chemicals against nuclear receptors and its application to identify PPARγ-bound fatty acids.
Jaladanki CK; He Y; Zhao LN; Maurer-Stroh S; Loo LH; Song H; Fan H
Arch Toxicol; 2021 Jan; 95(1):355-374. PubMed ID: 32909075
[TBL] [Abstract][Full Text] [Related]
42. Mechanism of Vitamin D Receptor Ligand-Binding Domain Regulation Studied by gREST Simulations.
Ekimoto T; Kudo T; Yamane T; Ikeguchi M
J Chem Inf Model; 2021 Jul; 61(7):3625-3637. PubMed ID: 34189910
[TBL] [Abstract][Full Text] [Related]
43. Structural mechanism underlying ligand binding and activation of PPARγ.
Shang J; Kojetin DJ
Structure; 2021 Sep; 29(9):940-950.e4. PubMed ID: 33713599
[TBL] [Abstract][Full Text] [Related]
44. A novel partial agonist of peroxisome proliferator-activated receptor-gamma (PPARgamma) recruits PPARgamma-coactivator-1alpha, prevents triglyceride accumulation, and potentiates insulin signaling in vitro.
Burgermeister E; Schnoebelen A; Flament A; Benz J; Stihle M; Gsell B; Rufer A; Ruf A; Kuhn B; Märki HP; Mizrahi J; Sebokova E; Niesor E; Meyer M
Mol Endocrinol; 2006 Apr; 20(4):809-30. PubMed ID: 16373399
[TBL] [Abstract][Full Text] [Related]
45. Ligand-escape pathways from the ligand-binding domain of PPARgamma receptor as probed by molecular dynamics simulations.
Genest D; Garnier N; Arrault A; Marot C; Morin-Allory L; Genest M
Eur Biophys J; 2008 Apr; 37(4):369-79. PubMed ID: 17929009
[TBL] [Abstract][Full Text] [Related]
46. Crystal structure of the peroxisome proliferator-activated receptor gamma (PPARgamma) ligand binding domain complexed with a novel partial agonist: a new region of the hydrophobic pocket could be exploited for drug design.
Montanari R; Saccoccia F; Scotti E; Crestani M; Godio C; Gilardi F; Loiodice F; Fracchiolla G; Laghezza A; Tortorella P; Lavecchia A; Novellino E; Mazza F; Aschi M; Pochetti G
J Med Chem; 2008 Dec; 51(24):7768-76. PubMed ID: 19053776
[TBL] [Abstract][Full Text] [Related]
47. Rational discovery of a novel interface for a coactivator in the peroxisome proliferator-activated receptor gamma: theoretical implications of impairment in type 2 diabetes mellitus.
Shiraki T; Kodama TS; Jingami H; Kamiya N
Proteins; 2005 Feb; 58(2):418-25. PubMed ID: 15558556
[TBL] [Abstract][Full Text] [Related]
48. An interpretation of positional displacement of the helix12 in nuclear receptors: preexistent swing-up motion triggered by ligand binding.
Watanabe C; Watanabe H; Tanaka S
Biochim Biophys Acta; 2010 Sep; 1804(9):1832-40. PubMed ID: 20601221
[TBL] [Abstract][Full Text] [Related]
49. Simulations reveal increased fluctuations in estrogen receptor-alpha conformation upon antagonist binding.
Ng HL
J Mol Graph Model; 2016 Sep; 69():72-7. PubMed ID: 27580485
[TBL] [Abstract][Full Text] [Related]
50. Definition of functionally and structurally distinct repressive states in the nuclear receptor PPARγ.
Heidari Z; Chrisman IM; Nemetchek MD; Novick SJ; Blayo AL; Patton T; Mendes DE; Diaz P; Kamenecka TM; Griffin PR; Hughes TS
Nat Commun; 2019 Dec; 10(1):5825. PubMed ID: 31862968
[TBL] [Abstract][Full Text] [Related]
51. Impaired helix 12 dynamics due to proline 892 substitutions in the androgen receptor are associated with complete androgen insensitivity.
Elhaji YA; Stoica I; Dennis S; Purisima EO; Lumbroso R; Beitel LK; Trifiro MA
Hum Mol Genet; 2006 Mar; 15(6):921-31. PubMed ID: 16449235
[TBL] [Abstract][Full Text] [Related]
52. A structural mechanism for directing corepressor-selective inverse agonism of PPARγ.
Brust R; Shang J; Fuhrmann J; Mosure SA; Bass J; Cano A; Heidari Z; Chrisman IM; Nemetchek MD; Blayo AL; Griffin PR; Kamenecka TM; Hughes TS; Kojetin DJ
Nat Commun; 2018 Nov; 9(1):4687. PubMed ID: 30409975
[TBL] [Abstract][Full Text] [Related]
53. DASH: a novel analysis method for molecular dynamics simulation data. Analysis of ligands of PPAR-gamma.
Salt DW; Hudson BD; Banting L; Ellis MJ; Ford MG
J Med Chem; 2005 May; 48(9):3214-20. PubMed ID: 15857127
[TBL] [Abstract][Full Text] [Related]
54. Structure-based identification of novel PPAR gamma ligands.
da Silva FM; dos Santos JC; Campos JL; Mafud AC; Polikarpov I; Figueira AC; Nascimento AS
Bioorg Med Chem Lett; 2013 Nov; 23(21):5795-802. PubMed ID: 24075729
[TBL] [Abstract][Full Text] [Related]
55. Discovery of Novel GR Ligands toward Druggable GR Antagonist Conformations Identified by MD Simulations and Markov State Model Analysis.
Hu X; Pang J; Zhang J; Shen C; Chai X; Wang E; Chen H; Wang X; Duan M; Fu W; Xu L; Kang Y; Li D; Xia H; Hou T
Adv Sci (Weinh); 2022 Jan; 9(3):e2102435. PubMed ID: 34825505
[TBL] [Abstract][Full Text] [Related]
56. Development of docking-based 3D-QSAR models for PPARgamma full agonists.
Guasch L; Sala E; Valls C; Mulero M; Pujadas G; Garcia-Vallvé S
J Mol Graph Model; 2012 Jun; 36():1-9. PubMed ID: 22503857
[TBL] [Abstract][Full Text] [Related]
57. Exploring the binding site structure of the PPAR gamma ligand-binding domain by computational solvent mapping.
Sheu SH; Kaya T; Waxman DJ; Vajda S
Biochemistry; 2005 Feb; 44(4):1193-209. PubMed ID: 15667213
[TBL] [Abstract][Full Text] [Related]
58. Study of the impact of the T877A mutation on ligand-induced helix-12 positioning of the androgen receptor resulted in design and synthesis of novel antiandrogens.
Zhou J; Liu B; Geng G; Wu JH
Proteins; 2010 Feb; 78(3):623-37. PubMed ID: 19787772
[TBL] [Abstract][Full Text] [Related]
59. Biochemical and structural basis for the pharmacological inhibition of nuclear hormone receptor PPARγ by inverse agonists.
Irwin S; Karr C; Furman C; Tsai J; Gee P; Banka D; Wibowo AS; Dementiev AA; O'Shea M; Yang J; Lowe J; Mitchell L; Ruppel S; Fekkes P; Zhu P; Korpal M; Larsen NA
J Biol Chem; 2022 Nov; 298(11):102539. PubMed ID: 36179791
[TBL] [Abstract][Full Text] [Related]
60. Molecular Recognition of PPARγ by Kinase Cdk5/p25: Insights from a Combination of Protein-Protein Docking and Adaptive Biasing Force Simulations.
Mottin M; Souza PC; Skaf MS
J Phys Chem B; 2015 Jul; 119(26):8330-9. PubMed ID: 26047365
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
